43 related articles for article (PubMed ID: 3408506)
1. Autoantibodies to IgE can induce the release of proinflammatory and vasoactive mediators from human cardiac mast cells.
Poto R; Patella V; Criscuolo G; Marone G; Coscioni E; Varricchi G
Clin Exp Med; 2023 Aug; 23(4):1265-1276. PubMed ID: 35879625
[TBL] [Abstract][Full Text] [Related]
2. IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells.
Poto R; Quinti I; Marone G; Taglialatela M; de Paulis A; Casolaro V; Varricchi G
Front Immunol; 2022; 13():880412. PubMed ID: 35711458
[TBL] [Abstract][Full Text] [Related]
3. IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target.
Lamri Y; Charles N
Antibodies (Basel); 2020 Dec; 9(4):. PubMed ID: 33302566
[TBL] [Abstract][Full Text] [Related]
4. Acid Stripping of Surface IgE Antibodies Bound to FcεRI is Unsuitable for the Functional Assays that Require Long-Term Culture of Basophils and Entire Removal of Surface IgE.
Galeotti C; Karnam A; Das M; Kaveri SV; Bayry J
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941161
[TBL] [Abstract][Full Text] [Related]
5. Lpr-induced systemic autoimmunity is unaffected by mast cell deficiency.
van Nieuwenhuijze AE; Cauwe B; Klatt D; Humblet-Baron S; Liston A
Immunol Cell Biol; 2015 Nov; 93(10):841-8. PubMed ID: 25849740
[TBL] [Abstract][Full Text] [Related]
6. "Auto-anti-IgE": naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation.
Chan YC; Ramadani F; Santos AF; Pillai P; Ohm-Laursen L; Harper CE; Fang C; Dodev TS; Wu SY; Ying S; Corrigan CJ; Gould HJ
J Allergy Clin Immunol; 2014 Dec; 134(6):1394-1401.e4. PubMed ID: 25112697
[TBL] [Abstract][Full Text] [Related]
7. Increased IgE serum levels are unrelated to allergic and parasitic diseases in patients with juvenile systemic lupus erythematosus.
Liphaus BL; Jesus AA; Silva CA; Coutinho A; Carneiro-Sampaio M
Clinics (Sao Paulo); 2012 Nov; 67(11):1275-80. PubMed ID: 23184203
[TBL] [Abstract][Full Text] [Related]
8. Polarization toward Th1-type response in active, but not in inactive, lupus inhibits late allergic rhinitis in lupus-prone female NZB×NZWF(1) mice.
Hayashi T; Murase A
Inflammation; 2012 Dec; 35(6):1753-63. PubMed ID: 22743757
[TBL] [Abstract][Full Text] [Related]
9. Current and novel therapeutics in the treatment of systemic lupus erythematosus.
Yildirim-Toruner C; Diamond B
J Allergy Clin Immunol; 2011 Feb; 127(2):303-12; quiz 313-4. PubMed ID: 21281862
[TBL] [Abstract][Full Text] [Related]
10. Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients.
Wozniacka A; Sysa-Jedrzejowska A; Robak E; Samochocki Z; Zak-Prelich M
Mediators Inflamm; 2003 Apr; 12(2):95-9. PubMed ID: 12775359
[TBL] [Abstract][Full Text] [Related]
11. IgE and non-IgE mediated allergic disorders in systemic lupus erythematosus.
Morton S; Palmer B; Muir K; Powell RJ
Ann Rheum Dis; 1998 Nov; 57(11):660-3. PubMed ID: 9924207
[TBL] [Abstract][Full Text] [Related]
12. Effects of leflunomide on immune responses and models of inflammation.
Bartlett RR; Anagnostopulos H; Zielinski T; Mattar T; Schleyerbach R
Springer Semin Immunopathol; 1993; 14(4):381-94. PubMed ID: 8322168
[No Abstract] [Full Text] [Related]
13. IgE-containing immune complexes in synovial fluid of patients with rheumatoid arthritis.
De Clerck LS; Struyf NJ; Bridts CH; Breedveld FC; Westedt ML; Cats A; Stevens WJ
Clin Rheumatol; 1990 Jun; 9(2):176-81. PubMed ID: 2390846
[TBL] [Abstract][Full Text] [Related]
14. Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.
Bartlett RR; Dimitrijevic M; Mattar T; Zielinski T; Germann T; Rüde E; Thoenes GH; Küchle CC; Schorlemmer HU; Bremer E
Agents Actions; 1991 Jan; 32(1-2):10-21. PubMed ID: 2058454
[TBL] [Abstract][Full Text] [Related]
15. Anti-IgE autoantibodies in systemic lupus erythematosus. Prevalence and biologic activity.
Gruber BL; Kaufman LD; Marchese MJ; Roth W; Kaplan AP
Arthritis Rheum; 1988 Aug; 31(8):1000-6. PubMed ID: 3408506
[TBL] [Abstract][Full Text] [Related]
16. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria.
Gyimesi E; Sipka S; Dankó K; Kiss E; Hídvégi B; Gál M; Hunyadi J; Irinyi B; Szegedi A
Br J Dermatol; 2004 Aug; 151(2):388-96. PubMed ID: 15327546
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes.
Gruber BL; Baeza ML; Marchese MJ; Agnello V; Kaplan AP
J Invest Dermatol; 1988 Feb; 90(2):213-7. PubMed ID: 2448392
[TBL] [Abstract][Full Text] [Related]
18. Anti-IgE autoantibodies in systemic sclerosis (scleroderma).
Kaufman LD; Gruber BL; Marchese MJ; Seibold JR
Ann Rheum Dis; 1989 Mar; 48(3):201-5. PubMed ID: 2930275
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
